Search

everythinglearnresearchcommunity

for

Search:↓

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Cell extracts may effectively and safely repair radiation-damaged salivary glands.

Antibody treatments show promise for hair loss but need more research.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Hydrogels show promise in preventing and treating skin damage from radiation therapy.

Imuvert can prevent some chemotherapy-induced hair loss.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

JAK inhibitors are effective treatments for alopecia areata.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

No treatment is completely effective for alopecia totalis and alopecia universalis.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Better supportive care is needed to manage chemotherapy side effects.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Nanotechnology can improve tissue healing by controlling immune responses.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.